Abstract
For decades, nurse practitioners (NPs) have faced a myriad of difficulties as they attempted to provide comprehensive patient care, including pharmacologic therapies. NPs have also struggled to remove constraints on their ability to practice to the full extent of their potential. Intensive legislative and regulatory work has been necessary to advance autonomous NP practice. This article examines issues surrounding removing barriers to practice. 1